Published in Medical Letter on the CDC and FDA, July 24th, 2005
The Power Infuser has been granted approval by the Canadian Regulatory Agency, Health Canada Therapeutic Products directorate (HCTPD), to begin marketing in Canada. In addition, the Power Infuser is now labeled with the CE Mark, allowing for the sale of the miniature fluid resuscitation pump in the European Union.
To qualify for the CE Mark, the Power Infuser was tested...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.